Catheter Precision Divests Non-Core Assets As It Shifts Focus
Catheter Precision (NYSE:VTAK) shares are down on Thursday as the company announced a strategic divestiture of its non-core assets.
VTAK Sells Atherectomy Catheter Tech to Focus on Electrophysiology
Catheter Precision on Thursday agreed to sell its atherectomy catheter technologies, including associated FDA approvals and patents, to a strategic acquirer.
This decision aims to enhance capital efficiency and sharpen the company’s focus on its high-growth electrophysiology platform.
The divestiture is expected to accelerate execution across its electrophysiology product portfolio while maintaining exposure to the future commercial success of the divested technologies. This strategic shift reflects the company’s commitment to advancing its core offerings in cardiac electrophysiology.
Transaction Highlights
Upfront cash payment following the closing of $15,000.
A 5% equity stake in the acquiring company with anti-dilution protection up to $5 million of additional equity capital being invested in the acquiring company.
Ten-year royalty payments agreement on net sales.
VTAK Stock Faces Bearish Trend Below SMA Levels
The stock is currently trading 21.1% below its 20-day simple moving average (SMA) and 31.7% below its 100-day SMA, indicating a bearish short-term trend.
Over the past 12 months, shares have decreased by 75.82% and are positioned closer to their 52-week lows than highs.
The RSI is at 44.39, which is considered neutral territory, while the MACD shows a value of -0.1249, below its signal line at -0.0886, indicating bearish pressure on the stock. The combination of neutral RSI and bearish MACD suggests mixed momentum.
- Key Resistance: $2.00
- Key Support: $1.50
VTAK Price Action: Catheter Precision shares were down 5.05% at $1.61 at the time of publication on Thursday. The stock is near its 52-week low of $1.13.
Photo via Shutterstock
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound extends losing streak against US Dollar, US PPI in focus
Barclays: US-Iran conflict unlikely to end in next 12 months, oil exports near 85% of pre-war level
Jensen Huang's sudden resignation shrouded in suspicion: Did the White House secretly intervene? Is a return possible in the future?
Only a few days separated Jensen Huang’s strong support from the board last Sunday and his late-night resignation on Wednesday. Multiple reports of the Wednesday night Nvidia board meeting were co-authored by Washington-based journalists—who do not typically cover Nvidia—fueling rumors of "White House pressure and information leaks." Huang’s unique value lies in leveraging his personal reputation to secure the supply chain and drive the implementation of technological roadmaps, making him difficult to replace. Some analysts note that, drawing on examples such as Steve Jobs’ return to Apple, it is possible that Huang may come back in the future.
Gold recovers from YTD low, retakes $3,900; Fed hike bets and bullish USD to cap gains
Crypto prices
More
